A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer

Clinical trial NCT04931654 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04931654
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Gastric Cancer Gastroesophageal Junction Cancer

Start date: 2021-09-28
Primary completion: 2024-12-04
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.